ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

THOR Synthorx Inc

67.99
0.00 (0.00%)
02 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Synthorx Inc NASDAQ:THOR NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 67.99 67.00 67.99 0 01:00:00

Thoratec Presentation At Leerink Global Healthcare Conference To Be Webcast

30/01/2015 1:45pm

PR Newswire (US)


Synthorx (NASDAQ:THOR)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Synthorx Charts.

PLEASANTON, Calif., Jan. 30, 2015 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Leerink Global Healthcare Conference on Thursday, February 12.

Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company beginning at 10:45 a.m., Eastern Standard Time (7:45 a.m., Pacific Standard Time). 

The presentation will be available through the conference website at http://leerink.metameetings.com/confbook/healthcare15/directlink?ticker=THOR, or on the company's website at http://www.thoratec.com.

Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's products include the HeartMate II® and HeartMate III™ LVAS (Left Ventricular Assist Systems) and Thoratec® VAD (Ventricular Assist Device) with more than 20,000 devices implanted in patients suffering from heart failure. Thoratec also manufactures and distributes the CentriMag®, PediMag®/PediVAS®, and HeartMate PHP™ product lines. HeartMate III is an investigational device and is limited by US law to investigational use. HeartMate PHP is currently in development and not approved for sale. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's website at http://www.thoratec.com.

Thoratec, the Thoratec logo, HeartMate, and HeartMate II are registered trademarks of Thoratec Corporation and HeartMate III, HeartMate PHP, and IVAD are trademarks of Thoratec Corporation. CentriMag and PediMag are registered trademarks of Thoratec LLC, and PediVAS is a registered trademark of Thoratec Switzerland GmbH.

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/thoratec-presentation-at-leerink-global-healthcare-conference-to-be-webcast-300027488.html

SOURCE Thoratec Corporation

Copyright 2015 PR Newswire

1 Year Synthorx Chart

1 Year Synthorx Chart

1 Month Synthorx Chart

1 Month Synthorx Chart

Your Recent History

Delayed Upgrade Clock